LINC01082

Across TCGA pan-cancer cohorts, LINC01082 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC01082 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher LINC01082 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01082 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.

OV, HNSC, and KIRC are the cancer types where LINC01082 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.304	0.654	.002	84	view →
HNSC	DFS	Tertile	III,IV	0.831	0.641	.003	81	view →
KIRC	DFS	Tertile	All	0.734	0.871	.006	69	view →
KIRP	OS	Tertile	II,III,IV	0.131	0.567	.006	57	view →
BRCA	DFS	Tertile	All	0.570	1.000	.033	36	view →
CESC	OS	Tertile	IV	0.091	0.593	<.001	36	view →
THCA	OS	Tertile	IV	0.095	0.966	<.001	36	view →
LGG	DFS	Tertile	All	0.462	0.744	<.001	30	view →
TGCT	DFS	Quartile	All	0.727	0.887	.015	26	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	24	view →
LUSC	DFS	Median	II,III,IV	0.245	0.474	.002	24	view →
PCPG	OS	Tertile	All	0.539	0.848	.013	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC01082–OV (OS)

Open the OV breakdown →